
### [NCIT:C9295](http://purl.obolibrary.org/obo/NCIT_C9295)
**Label:** Mast Cell Neoplasm

**Subclasses:** [NCIT:C3169](http://purl.obolibrary.org/obo/NCIT_C3169) (Mast Cell Leukemia), [NCIT:C3217](http://purl.obolibrary.org/obo/NCIT_C3217) (Benign Mastocytoma), [NCIT:C43284](http://purl.obolibrary.org/obo/NCIT_C43284) (Primary Systemic Mastocytosis), [NCIT:C9303](http://purl.obolibrary.org/obo/NCIT_C9303) (Mastocytoma), [NCIT:C84269](http://purl.obolibrary.org/obo/NCIT_C84269) (Mastocytosis), [NCIT:C9348](http://purl.obolibrary.org/obo/NCIT_C9348) (Mast Cell Sarcoma), [NCIT:C7137](http://purl.obolibrary.org/obo/NCIT_C7137) (Cutaneous Mastocytosis), [NCIT:C43277](http://purl.obolibrary.org/obo/NCIT_C43277) (Pure Cutaneous Mastocytosis), [NCIT:C9235](http://purl.obolibrary.org/obo/NCIT_C9235) (Systemic Mastocytosis), [NCIT:C7136](http://purl.obolibrary.org/obo/NCIT_C7136) (Extracutaneous Mastocytoma), [NCIT:C8991](http://purl.obolibrary.org/obo/NCIT_C8991) (Malignant Mastocytosis), [NCIT:C9286](http://purl.obolibrary.org/obo/NCIT_C9286) (Indolent Systemic Mastocytosis), [NCIT:C9284](http://purl.obolibrary.org/obo/NCIT_C9284) (Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN)), [NCIT:C9285](http://purl.obolibrary.org/obo/NCIT_C9285) (Aggressive Systemic Mastocytosis), 

**Class expressions from DL-Learner:**

- Thing 52.12%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 42.50%


